Senior Director, Search & Evaluation Late TA Lead, Immunology

CSL

Schweiz

Híbrido

CHF 250.000 - 420.000

Jornada completa

14 días+

Una candidatura completa en un minuto

Currículum y carta de presentación personalizados, listos para enviar.

Supera los filtros ATS

Descripción de la vacante

CSL Behring is expanding its external innovation capability and seeks a Senior Director of Search & Evaluation to shape the Immunology portfolio. This leader will drive strategic sourcing and evaluation of late-stage assets from Phase 2 to marketed drugs, engaging with KOLs and investigators and coordinating multi-disciplinary due diligence.

Hybrid role based onsite three days a week at our R&D hub sites in Zurich (CH), Maidenhead (UK), Waltham (US), or King of Prussia (US).

Formación

  • 15+ years in biopharma with clinical development/external innovation or business development
  • Deep clinical expertise in Immunology
  • Proven track record of sourcing and closing late-stage deals with KOLs and investigators
  • Knowledge of regulatory pathways, market access, and standards of care

Responsabilidades

  • Lead senior S&E strategy within the Therapy Area Leadership Team
  • Oversee proactive sourcing for Phase 2 to marketed assets aligned with TA strategy
  • Coordinate due diligence across clinical, regulatory, commercial and market access
  • Engage with external KOLs and investigators to validate potential assets
  • Represent sourcing activities at conferences and external networks
  • Partner with BD and regional leads to progress opportunities to deal close

Conocimientos

Sourcing & deals
KOL engagement
Clinical development
Strategic leadership
Stakeholder management

Educación

MD/PhD or equivalent

Descripción del empleo

CSL is expanding its external innovation capability, and we're looking for a Senior Director of Search & Evaluation to help shape the future of our Immunology portfolio.

We are seeking a Senior Director of Search & Evaluation to lead strategic sourcing and evaluation of later-stage external clinical assets in Immunology . This leader will focus on opportunities from Phase 2 through marketed drugs, requiring deep clinical expertise, strong engagement with external Key Opinion Leaders (KOLs) and clinical investigators, and a keen understanding of evolving standards of care. The role is critical to shaping our portfolio through high-impact partnerships and transactions.

To be hybrid-based onsite (3 days a week) at one of our R&D hub sites: Zurich (CH), Maidenhead (UK), Waltham (US), King of Prussia (US). This position cannot be held remotely

Main Responsibilities & Accountabilities
  • Serve as the senior S&E leader within the Therapy Area Leadership Team, influencing therapeutic strategy and integrating late-stage external innovation priorities into portfolio planning.
  • Lead proactive sourcing efforts for Phase 2 to marketed assets, identifying opportunities that align with TA strategy and unmet medical needs.
  • Co-lead internal meetings (with Early Search Lead) focused on evaluating and prioritizing New Product Opportunities (NPOs) within Immunology. NPO meetings are strategic checkpoints where cross-functional teams review potential assets identified by Search and decide whether to advance them for further due diligence and deal negotiations.
  • Engage extensively with external KOLs, clinical investigators, and networks to validate asset potential, understand trial designs & clinical endpoints, and anticipate competitive dynamics.
  • Maintain deep awareness of changing standards of care and competitive landscapes to inform sourcing priorities and deal strategy.
  • Drive cross-functional due diligence for late-stage assets, coordinating clinical, regulatory, commercial, and market access assessments to support governance decisions.
  • Partner closely with BD and Regional Ecosystem Leads to advance high-priority opportunities through negotiation and deal close, ensuring seamless handoff and execution
  • Represent the TA externally, leading sourcing activities at specialized conferences and building relationships with pharma, biotech, and clinical communities.
Qualifications & Experience Requirements
  • 15+ years in biopharma with significant experience in clinical development, external innovation, or business development.
  • Advanced degree required (MD, PhD, or equivalent).
  • Deep clinical expertise in Immunology
  • Proven track record of sourcing and closing late-stage deals and engaging with KOLs and clinical networks.
  • Strong understanding of regulatory pathways, market access, and competitive standards of care.
About CSL Behring

CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients' needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.

CSL Behring operates one of the world's largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.

To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/ .

Our Benefits

For more information on CSL benefits visit How CSL Supports Your Well-being | CSL .

You Belong at CSL

At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future.

Equal Opportunity Employer

CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://www.csl.com/accessibility-statement .

Consigue la evaluación confidencial y gratuita de tu currículum.

o arrastra y suelta tu archivo aquí

Similar jobs

Puestos de trabajo similares que vale la pena comparar

Senior Director, Search & Evaluation Late TA Lead, Immunology
Senior Director, Search & Evaluation Late TA Lead, Immunology

CSL • Glattbrugg

Híbrido
CHF 250.000 - 420.000
Senior Director, Search & Evaluation Late TA Lead, Immunology
Senior Director, Search & Evaluation Late TA Lead, Immunology

CSL • Zürich

Híbrido
CHF 280.000 - 420.000
Medical Director, Global Clinical Program Lead - Immunology/Immunoglobulins
Medical Director, Global Clinical Program Lead - Immunology/Immunoglobulins

CSL • Glattbrugg

Híbrido
CHF 247.000 - 310.000
Hybrid work model
Global exposure to CS L Behring teams
Medical Director, Global Clinical Program Leader - Immunology
Medical Director, Global Clinical Program Leader - Immunology

CSL • Opfikon

Presencial
CHF 247.000 - 310.000
Associate Director, Analytical Strategy
Associate Director, Analytical Strategy

CSL • Bern

Presencial
CHF 180.000 - 240.000
Director, Global Clinical Program Lead
Director, Global Clinical Program Lead

1055 CSL Behring (NL) • Glattbrugg

Híbrido
CHF 240.000 - 320.000
Inclusion and Belonging
Equal Opportunity Employer
Global Principal Clinical Scientist - Cardiorenal
Global Principal Clinical Scientist - Cardiorenal

CSL • Glattbrugg

Presencial
CHF 180.000 - 260.000
Director, Global Clinical Program Lead
Director, Global Clinical Program Lead

Biopharma Asia • Basel

Híbrido
CHF 180.000 - 240.000
Global Regulatory Lead
Global Regulatory Lead

CSL • Opfikon

Híbrido
CHF 197.000 - 220.000
Director, Global Clinical Program Lead
Director, Global Clinical Program Lead

CSL Behring KK • Glattbrugg

A distancia
CHF 180.000 - 280.000
Ubicaciones